Statistics

Total Visits

Views
Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)2

Select a period of time:

Number of views in the range

Views
Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)2

Views

Views
February 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
France2
 

Top cities views

Views